Ekso Bionics Holdings, Inc.
EKSO
$0.4599
$0.055313.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.45% | 26.59% | 22.84% | 4.11% | -0.78% |
| Total Depreciation and Amortization | -5.30% | 7.74% | 30.94% | 57.94% | 91.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.33% | -22.27% | 27.21% | 47.01% | -2.69% |
| Change in Net Operating Assets | -333.10% | 14.71% | -1,202.14% | 59.98% | 77.40% |
| Cash from Operations | 18.32% | 29.17% | 17.06% | 23.07% | 17.93% |
| Capital Expenditure | 76.43% | 64.67% | 76.63% | 47.88% | 19.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.43% | 98.85% | 98.71% | 97.64% | 96.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -299.36% | -- | -- | -- | -- |
| Issuance of Common Stock | 1,264.75% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,132.47% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -29.17% | -205.26% | -216.67% | -485.71% | -33.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.96% | 91.45% | 60.11% | 62.42% | 40.21% |
